[18F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462). | Neurology;42(1): 199-203, 1992 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

[18F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462).

Laihinen, A; Rinne, J O; Rinne, U K; Haaparanta, M; Ruotsalainen, U; Bergman, J; Solin, O.

Affiliation

Laihinen A; Department of Neurology, University of Turku, Finland.

Neurology ; 42(1): 199-203, 1992 Jan.

Article in En | MEDLINE | ID: mdl-1734304

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Pentanones / Tomography, Emission-Computed / Catechols / Catechol O-Methyltransferase Inhibitors Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 1992 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Pentanones / Tomography, Emission-Computed / Catechols / Catechol O-Methyltransferase Inhibitors Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 1992 Document type: Article Affiliation country: Country of publication: